|
Diabetes, Vol 38, Issue 5 580-588, Copyright © 1989 by American Diabetes Association
Bedtime insulin for suppression of overnight free-fatty acid, blood glucose, and glucose production in NIDDM
MR Taskinen, T Sane, E Helve, SL Karonen, EA Nikkila and H Yki-Jarvinen
Second Department of Medicine, University of Helsinki, Finland.
We studied the clinical effectiveness and mechanism underlying the
glucose-lowering effect of evening insulin therapy. Nocturnal profiles of
blood glucose, plasma free fatty acid (FFA), glycerol, and lactate and
overnight glucose kinetics [( 3-3H] glucose infusion) were measured in 15
non-insulin-dependent diabetic (NIDDM) patients with a relative body weight
of 128 +/-4% who were poorly controlled with oral therapy alone. The
patients were studied before and 2 wk and 3 mo after bedtime insulin (23
+/- 3 IU) was given in addition to oral therapy. An early-morning rise in
blood glucose (greater than 31 mg/dl = 1.5 mM) was present in two-thirds of
the patients and was associated with an overnight rise in plasma FFA and an
increase in glucose production (Ra) during the early-morning hours (change
0.42 +/- 0.10 mg.kg-1.min-1, P less than .05, between 0300 and 0800). The
overnight mean levels of blood glucose, plasma FFA, and serum insulin
averaged 212 +/- 9 vs. 137 +/- 11 vs. 133 +/- 11 mg/dl (P less than .001),
674 +/- 61 vs. 491 +/- 57 vs. 484 +/- 36 microM (P less than 0.01) and 12.7
+/- 1.6 vs. 18.1 +/- 2.2 vs. 20.7 +/- 2.4 microU/L (P less than .01) before
and 2 wk and 3 mo after the combination therapy. The decrements in
overnight glucose and FFA levels after 2 wk of bedtime insulin therapy were
closely correlated (r = .86, (P less than .001). The nocturnal profile of
plasma lactate was similar before and during bedtime insulin
therapy.(ABSTRACT TRUNCATED AT 250 WORDS)

CiteULike Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
S. P. Kim, K. J. Catalano, I. R. Hsu, J. D. Chiu, J. M. Richey, and R. N. Bergman
Nocturnal free fatty acids are uniquely elevated in the longitudinal development of diet-induced insulin resistance and hyperinsulinemia
Am J Physiol Endocrinol Metab,
June 1, 2007;
292(6):
E1590 - E1598.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Vehkavaara and H. Yki-Jarvinen
3.5 Years of Insulin Therapy With Insulin Glargine Improves In Vivo Endothelial Function in Type 2 Diabetes
Arterioscler. Thromb. Vasc. Biol.,
February 1, 2004;
24(2):
325 - 330.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
M. C. Riddle, J. Rosenstock, and J. Gerich
The Treat-to-Target Trial: Randomized addition of glargine or human NPH insulin to oral therapy of type 2 diabetic patients
Diabetes Care,
November 1, 2003;
26(11):
3080 - 3086.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. M. Miles, D. Wooldridge, W. J. Grellner, S. Windsor, W. L. Isley, S. Klein, and W. S. Harris
Nocturnal and Postprandial Free Fatty Acid Kinetics in Normal and Type 2 Diabetic Subjects: Effects of Insulin Sensitization Therapy
Diabetes,
March 1, 2003;
52(3):
675 - 681.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M D. Robertson, R A. Henderson, G. E Vist, and R D. E Rumsey
Extended effects of evening meal carbohydrate-to-fat ratio on fasting and postprandial substrate metabolism
Am. J. Clinical Nutrition,
March 1, 2002;
75(3):
505 - 510.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Vehkavaara, S. Makimattila, A. Schlenzka, J. Vakkilainen, J. Westerbacka, and H. Yki-Jarvinen
Insulin Therapy Improves Endothelial Function in Type 2 Diabetes
Arterioscler. Thromb. Vasc. Biol.,
February 1, 2000;
20(2):
545 - 550.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. Basu, A. Basu, M. Nielsen, P. Shah, and R. A. Rizza
Effect of Overnight Restoration of Euglycemia on Glucose Effectiveness in Type 2 Diabetes Mellitus
J. Clin. Endocrinol. Metab.,
July 1, 1999;
84(7):
2314 - 2319.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
J. A. Colwell
The Feasibility of Intensive Insulin Management in Non-Insulin-dependent Diabetes Mellitus: Implications of the Veterans Affairs Cooperative Study on Glycemic Control and Complications in NIDDM
Ann Intern Med,
January 1, 1996;
124(1_Part_2):
131 - 135.
[Abstract]
[Full Text]
|
 |
|
Copyright © 1989 by the American Diabetes Association.
|
|
| |
|